The Uromigos
A podcast by The Uromigos
401 Episoade
-
Episode 363: 前立腺がんの最新の話題〜T cell directed therapyとradioligands〜
Publicat: 24.10.2024 -
Episode 362: 膀胱がんの最新の話題〜周術期薬物療法とADC〜
Publicat: 24.10.2024 -
Episode 361: The Role of Monotherapy AR Inhibition in Prostate Cancer
Publicat: 22.10.2024 -
Episode 360: The SUNRISE Program in Bladder Cancer
Publicat: 15.10.2024 -
Episode 359: #UromigosLive24 - IO after IO in RCC
Publicat: 09.10.2024 -
Episode 358: Noticias del Dia 1 de Uromigos Live 2024 en Nashville
Publicat: 30.09.2024 -
Episode 357: #UromigosLive24 - Peri-operative Therapy in Bladder Cancer
Publicat: 30.09.2024 -
Episode 356: #UromigosLive24 - Front-line Therapy in Papillary and Non-clear Cell RCC
Publicat: 28.09.2024 -
Episode 355: #UromigosLive24 - Radioligands in prostate cancer
Publicat: 28.09.2024 -
Episode 354: #UromigosLive24 - T cell directed therapy in prostate cancer
Publicat: 28.09.2024 -
Episode 353: #UromigosLive24 ADC session
Publicat: 28.09.2024 -
Episode 352: ESMO 2024 - RCC and Bladder review
Publicat: 23.09.2024 -
Episode 351: ESMO 2024 review part 1: prostate cancer
Publicat: 21.09.2024 -
Episode 350: ESMO 2024 - NIAGARA
Publicat: 16.09.2024 -
Episode 349: ESMO 2024 - Uromigos Japan!!
Publicat: 16.09.2024 -
Episode 348: ESMO 2024 - UpFrontPSMA
Publicat: 15.09.2024 -
Episode 347: ESMO 2024 - DV + Pembro in Urothelial Cancer
Publicat: 15.09.2024 -
Episode 346: ESMO 2024 - PEACE-3: Enza/Radium-223 vs Enza in mCRPC
Publicat: 14.09.2024 -
Episode 345: ESMO 2024 - SUNNIFORECAST: Ipi/Nivo vs SOC in Non-clear Cell RCC
Publicat: 14.09.2024 -
Episode 344: ESMO 2024 - NKT2152, a HIF inhibitor in RCC
Publicat: 14.09.2024
Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
